Clinical Study
Gastric Cancer in the Young: Is It a Different Clinical Entity? A Retrospective Cohort Study
Table 2
Pathologic characteristics of operated gastric tumors.
| | Parameter | <50 years
(20) | ≥50 years
(112) | |
| | Mean tumor diameter (cm) ± SD | | | 0.461 | | Median | 4 | 4 | | Tumor site | | | | | Upper third | 4 (20.0%) | 23 (20.5%) | 0.806 | | Middle third | 4 (20.0%) | 27 (24.1%) | | Lower third | 12 (60.0%) | 60 (53.6%) | | Whole stomach | 0 (0%) | 2 (1.8%) | | Depth of cancer invasion | | | | | Early | 4 (20.0%) | 15 (13.4%) | 0.667 | | Advanced | 16 (80.0%) | 97 (86.6%) | | Histological type (Lauren’s criteria) | | | | | Intestinal | 6 (30.0%) | 65 (58.0%) | 0.038 | | Diffuse | 14 (70.0%) | 47 (42.0%) | | Lymph node metastasis | | | | | Positive | 13 (65.0%) | 63 (56.2%) | 0.629 | | Negative | 7 (35.0%) | 49 (43.8%) | | Stage TNM 6th edition | | | | | I | 7 (35.0%) | 38 (34.9%) | 0.871 | | II | 2 (10.0%) | 31 (27.7%) | | III | 6 (30.0%) | 31 (27.7%) | | IV | 5 (25.0%) | 12 (10.7%) |
|
|
SD: standard deviation; TNM: tumor node metastasis; values are bilateral.
|
